CRL logo

CRL
Charles River Laboratories International Inc.

912
Mkt Cap
$8.56B
Volume
68.00
52W High
$228.88
52W Low
$91.86
PE Ratio
-56.90
CRL Fundamentals
Price
$168.22
Prev Close
$173.89
Open
$170.56
50D MA
$175.61
Beta
1.45
Avg. Volume
898,440.65
EPS (Annual)
-$2.91
P/B
2.62
Rev/Employee
$203,826.50
$12,557.80
Loading...
Loading...
News
all
press releases
Aberdeen Group plc Purchases 88,853 Shares of Charles River Laboratories International, Inc. $CRL
Aberdeen Group plc grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1,090.5% during the fourth quarter, according to the company in its most recent...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Charles River Laboratories International (NYSE:CRL) Shares Down 3.7% - Here's Why
Charles River Laboratories International (NYSE:CRL) Shares Down 3.7% - Here's Why...
MarketBeat·18h ago
News Placeholder
NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX
NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX PR Newswire NEW YORK, April 6, 2026 NYSE...
PR Newswire·22h ago
News Placeholder
Lawson Kroeker Investment Management Inc. NE Sells 18,277 Shares of Charles River Laboratories International, Inc. $CRL
Lawson Kroeker Investment Management Inc. NE trimmed its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 36.6% during the fourth quarter, according to...
MarketBeat·3d ago
News Placeholder
Assenagon Asset Management S.A. Increases Stake in Charles River Laboratories International, Inc. $CRL
Assenagon Asset Management S.A. increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 104.0% during the 4th quarter, according to its most recent Form 13F...
MarketBeat·10d ago
News Placeholder
Riverbridge Partners LLC Reduces Stock Position in Charles River Laboratories International, Inc. $CRL
Riverbridge Partners LLC lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 20.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 99,328 shares of the medical research company...
MarketBeat·11d ago
News Placeholder
SG Americas Securities LLC Invests $36.26 Million in Charles River Laboratories International, Inc. $CRL
SG Americas Securities LLC acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 4th quarter, according to its most recent Form 13F...
MarketBeat·12d ago
News Placeholder
10,284 Shares in Charles River Laboratories International, Inc. $CRL Purchased by Oliver Luxxe Assets LLC
Oliver Luxxe Assets LLC acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 10,284 shares of the medical research co...
MarketBeat·16d ago
News Placeholder
JPMorgan Chase & Co. Raises Stake in Charles River Laboratories International, Inc. $CRL
JPMorgan Chase & Co. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 14.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 317,179 shares of the medical research compan...
MarketBeat·17d ago
News Placeholder
Why Is Charles River (CRL) Down 6.8% Since Last Earnings Report?
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·18d ago
<
1
2
...
>

Latest CRL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.